(Q68727565)
Statements
Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma (English)
Lopez M
Di Lauro L
Papaldo P
Ganzina F
Di Pietro N
scientific article published on 01 July 1986